Brief: Natco Pharma Says Sept-Quarter Consol Net Profit At 6.77 Billion Rupees
12/11/2024 09:38
Nov 12 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA SEPT-QUARTER CONSOL NET PROFIT 6.77 BILLION
RUPEES
* NATCO PHARMA SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS
13.71
BILLION RUPEES
* NATCO PHARMA - DIVIDEND OF 1.5 RUPEESPER SHARE
Source text: ID:
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees